Establishment of an efficient multiplex real-time PCR assay for human papillomavirus genotyping in cervical cytology specimens: Comparison with hybrid capture II

Cytopathology

Volumn 22, Issue 4, 2011, Pages 261-268

  Lee, J H ^a   Lee, N W ^a   Hong, S W ^b   Nam, Y S ^b   Choi, J W ^a   Kim, Y S ^a  

^a Korea University College of Medicine   (South Korea)

^b Kogenebiotech Co   (South Korea)

Author keywords

Cervical cytology; Genotyping; Human papillomavirus; Hybrid capture; Multiplex real time PCR

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; CYTOLOGY; CYTOPATHOLOGY; DNA SEQUENCE; FEMALE; GENE AMPLIFICATION; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYBRID CAPTURE II; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NUCLEIC ACID ANALYSIS; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TEMPERATURE; VIRUS GENE; WART VIRUS;

FEMALE; GENOTYPE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; UTERINE CERVICAL NEOPLASMS;

EID: 79960481182     PISSN: 09565507     EISSN: 13652303     Source Type: Journal    
DOI: 10.1111/j.1365-2303.2010.00787.x     Document Type: Article

References (22)

1. Munoz N, Bosch FX, de Sanjose S et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-27.
2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
3. Schiffman M, Herrero R, Desalle R et al. The carcinogenicity of human papillomavirus types reflects viral evolution. Virology 2005;337:76-84.
4. Molijn A, Kleter B, Quint W, van Doorn LJ. Molecular diagnosis of human papillomavirus (HPV) infections. J Clin Virol 2005;32(Suppl. 1):S43-51.
5. Frazer IH. Prevention of cervical cancer through papillomavirus vaccination. Nat Rev Immunol 2004;4:46-54.
6. Zhou J, Sun XY, Stenzel DJ, Frazer IH. Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles. Virology 1991;185:251-7.
7. Kirnbauer R, Taub J, Greenstone H et al. Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles. J Virol 1993;67:6929-36.
8. Gravitt PE, Peyton CL, Apple RJ, Wheeler CM. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol 1998;36:3020-7.
9. Gravitt PE, Peyton CL, Alessi TQ et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol 2000;38:357-61.
10. Kleter B, van Doorn LJ, Schrauwen L et al. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol 1999;37:2508-17.
11. Cuzick J, Clavel C, Petry KU et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer 2006;119:1095-101.
12. Castle PE, Wheeler CM, Solomon D et al. Interlaboratory reliability of Hybrid Capture 2. Am J Clin Pathol 2004;122:238-45.
13. Carozzi FM, Del Mistro A, Confortini M et al. Reproducibility of HPV DNA testing by Hybrid Capture 2 in a screening setting. Am J Clin Pathol 2005;124:716-21.
14. O'Neill CJ, McCluggage WG. p16 expression in the female genital tract and its value in diagnosis. Adv Anat Pathol 2006;13:8-15.
15. Hu L, Guo M, He Z et al. Human papillomavirus genotyping and p16INK4a expression in cervical intraepithelial neoplasia of adolescents. Mod Pathol 2005;18:267-73.
16. Mulvany NJ, Allen DG, Wilson SM. Diagnostic utility of p16INK4a: a reappraisal of its use in cervical biopsies. Pathology 2008;40:335-44.
17. Meijer CJ, Snijders PJ, Castle PE. Clinical utility of HPV genotyping. Gynecol Oncol 2006;103:12-7.
18. Takacs T, Jeney C, Kovacs L et al. Molecular beacon-based real-time PCR method for detection of 15 high-risk and 5 low-risk HPV types. J Virol Methods 2008;149:153-62.
19. Schmitz M, Scheungraber C, Herrmann J et al. Quantitative multiplex PCR assay for the detection of the seven clinically most relevant high-risk HPV types. J Clin Virol 2009;44:302-7.
20. Spinillo A, Dal Bello B, Gardella B et al. Multiple human papillomavirus infection and high grade cervical intraepithelial neoplasia among women with cytological diagnosis of atypical squamous cells of undetermined significance or low grade squamous intraepithelial lesions. Gynecol Oncol 2009;113:115-9.
21. Lee SA, Kang D, Seo SS et al. Multiple HPV infection in cervical cancer screened by HPVDNAChip. Cancer Lett 2003;198:187-92.
22. Cuschieri KS, Cubie HA, Whitley MW et al. Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population. J Clin Pathol 2004;57:68-72.